Jinling Xu
Guangdong And Shenzhen Key Laboratory Of Male Reproductive Medicine And Genetics, P.R. China
Shenzhen, China
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Erratum: [Corrigendum] miR‑216a‑5p acts as an oncogene in renal cell carcinoma.
Journal: Experimental and therapeutic medicine
Published: March 13, 2024
Erratum: [Corrigendum] miR‑199b‑5p serves as a tumor suppressor in renal cell carcinoma.
Journal: Experimental and therapeutic medicine
Published: February 28, 2024
miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery.
Journal: The International journal of biological markers
Published: August 06, 2019
miR-625-3p promotes migration and invasion and reduces apoptosis of clear cell renal cell carcinoma.
miR-625-3p promotes migration and invasion and reduces apoptosis of clear cell renal cell carcinoma.
Journal: American journal of translational research
Published: May 18, 2019
Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
Upregulation of miR-183-5p predicts worse survival in patients with renal cell cancer after surgery.
Journal: Cancer biomarkers : section A of Disease markers
Published: January 29, 2019
Erratum: miR-199b-5p serves as a tumor suppressor in renal cell carcinoma.
Journal: Experimental and therapeutic medicine
Published: August 23, 2018
MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients.
Journal: American journal of translational research
Published: June 13, 2018
[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
Journal: International journal of molecular medicine
Published: May 06, 2018
MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma.
Journal: International journal of molecular medicine
Published: May 06, 2018
Identification of miR-18a-5p as an oncogene and prognostic biomarker in RCC.
Journal: American journal of translational research
Published: February 11, 2018
microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Journal: Oncology reports
Published: January 24, 2018
microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
Journal: Molecular medicine reports
Published: June 01, 2017
Last Updated: 09/26/2026